Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-010713
Filing Date
2025-03-05
Accepted
2025-03-05 19:53:26
Documents
1
Period of Report
2025-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741222400.html 4  
1 FORM 4 wk-form4_1741222400.xml 4 28727
  Complete submission text file 0001628280-25-010713.txt   30133
Mailing Address 103 JFK PARKWAY SHORT HILLS NJ 07078
Business Address
Konidaris Tasos (Reporting) CIK: 0001320982 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 25713158

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)